Safety proved drugs classified as non-professional drugs.

Published: 2000-04-03 11:16:00

Updated: 2000-04-03 11:16:00

The KPMA suggested to the MOHW that it should be classified as a general drug (non-prescription drug) if the drug having formulated with new ingredients for the first time in Korea had been sufficiently proved its safety and efficacy and classified as a general drug in the foreign country.

The...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK